| Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups D Taïeb, A Jha, G Treglia, K Pacak Endocrine-related cancer 26 (11), R627-R652, 2019 | 86 | 2019 |
| Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related … A Jha, A Ling, C Millo, G Gupta, B Viana, FI Lin, P Herscovitch, KT Adams, ... European journal of nuclear medicine and molecular imaging 45, 787-797, 2018 | 84 | 2018 |
| Imaging of pheochromocytoma and paraganglioma JA Carrasquillo, CC Chen, A Jha, A Ling, FI Lin, DA Pryma, K Pacak Journal of Nuclear Medicine 62 (8), 1033-1042, 2021 | 76 | 2021 |
| High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma A Jha, D Taïeb, JA Carrasquillo, DA Pryma, M Patel, C Millo, ... Clinical Cancer Research 27 (11), 2989-2995, 2021 | 68 | 2021 |
| Emerging treatments for advanced/metastatic pheochromocytoma and paraganglioma M Ilanchezhian, A Jha, K Pacak, J Del Rivero Current Treatment Options in Oncology 21, 1-18, 2020 | 64 | 2020 |
| Multiparametric evaluation in differentiating glioma recurrence from treatment-induced necrosis using simultaneous 18F-FDG-PET/MRI: a single-institution retrospective study A Jena, S Taneja, A Jha, NK Damesha, P Negi, GK Jadhav, SM Verma, ... American Journal of Neuroradiology 38 (5), 899-907, 2017 | 50 | 2017 |
| Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma A Jha, K De Luna, CA Balili, C Millo, CA Paraiso, A Ling, MK Gonzales, ... Frontiers in Oncology 9, 53, 2019 | 47 | 2019 |
| 68Ga-PSMA uptake in hepatocellular carcinoma S Taneja, R Taneja, V Kashyap, A Jha, A Jena Clinical Nuclear Medicine 42 (1), e69-e70, 2017 | 46 | 2017 |
| Somatostatin receptors and analogs in pheochromocytoma and paraganglioma: old players in a new precision medicine world M Patel, I Tena, A Jha, D Taieb, K Pacak Frontiers in Endocrinology 12, 625312, 2021 | 39 | 2021 |
| 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma D Taïeb, A Jha, C Guerin, Y Pang, KT Adams, CC Chen, P Romanet, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1574-1582, 2018 | 39 | 2018 |
| Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents I Jochmanova, AMT Abcede, RJS Guerrero, CLP Malong, R Wesley, ... Journal of cancer research and clinical oncology 146, 1051-1063, 2020 | 37 | 2020 |
| Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants D Taïeb, GB Wanna, M Ahmad, C Lussey-Lepoutre, ND Perrier, S Nölting, ... The Lancet Diabetes & Endocrinology 11 (5), 345-361, 2023 | 34 | 2023 |
| Comprehensive review of evaluation and management of cardiac paragangliomas SH Tella, A Jha, D Taïeb, KA Horvath, K Pacak Heart 106 (16), 1202-1210, 2020 | 31 | 2020 |
| The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using mannan-BAM, TLR ligands … V Caisova, L Li, G Gupta, I Jochmanova, A Jha, O Uher, TT Huynh, ... Cancers 11 (5), 654, 2019 | 31 | 2019 |
| Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation Z Abdul Sater, A Jha, A Hamimi, A Mandl, IR Hartley, S Gubbi, M Patel, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), 1176-1185, 2020 | 22 | 2020 |
| Systemic radiopharmaceutical therapy of pheochromocytoma and paraganglioma JA Carrasquillo, CC Chen, A Jha, K Pacak, DA Pryma, FI Lin Journal of Nuclear Medicine 62 (9), 1192-1199, 2021 | 20 | 2021 |
| Developmental vascular malformations in EPAS1 gain-of-function syndrome JS Rosenblum, H Wang, PM Dmitriev, AJ Cappadona, P Mastorakos, ... JCI insight 6 (5), 2021 | 18 | 2021 |
| Prospective evaluation of 68Ga‐DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers S Gabriel, P Garrigue, L Dahan, F Castinetti, F Sebag, K Baumstark, ... Clinical endocrinology 89 (2), 155-163, 2018 | 18 | 2018 |
| Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and … A Jha, M Patel, JA Carrasquillo, A Ling, C Millo, B Saboury, CC Chen, ... American Journal of Roentgenology 218 (2), 342-350, 2022 | 16 | 2022 |
| Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement D Taïeb, S Nölting, ND Perrier, M Fassnacht, JA Carrasquillo, ... Nature Reviews Endocrinology 20 (3), 168-184, 2024 | 15 | 2024 |
